TriSalus Life Sciences (NASDAQ:TLSI) Earns Buy Rating from Analysts at Canaccord Genuity Group
Canaccord Genuity Group began coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a report published on Thursday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $12.00 price objective on the stock. TLSI has been the subject of several other reports. Jonestrading started coverage on shares of TriSalus Life […]
More Stories
Israeli forces fire on UN peacekeepers in Lebanon
Israel Defense Forces (IDF) fired on UN peacekeepers in Lebanon early Thursday morning, according to UNIFIL, the mission operating along...
PIMCO High Income Fund (NYSE:PHK) to Issue $0.05 Monthly Dividend
PIMCO High Income Fund (NYSE:PHK – Get Free Report) announced a monthly dividend on Tuesday, October 1st, NASDAQ reports. Investors...
PIMCO Municipal Income Fund Plans Monthly Dividend of $0.04 (NYSE:PMF)
PIMCO Municipal Income Fund (NYSE:PMF – Get Free Report) announced a monthly dividend on Tuesday, October 1st, NASDAQ reports. Stockholders...
Pyxis Tankers Inc. (NASDAQ:PXSAP) Plans $0.16 Monthly Dividend
Pyxis Tankers Inc. (NASDAQ:PXSAP – Get Free Report) declared a monthly dividend on Tuesday, October 1st, investing.com reports. Stockholders of...
Pimco Dynamic Income Opportunities Fund (NYSE:PDO) to Issue $0.13 Monthly Dividend
Pimco Dynamic Income Opportunities Fund (NYSE:PDO – Get Free Report) declared a monthly dividend on Tuesday, October 1st, NASDAQ reports....
ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN (NYSEARCA:CEFD) Plans Dividend Increase – $0.29 Per Share
ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN (NYSEARCA:CEFD – Get Free Report) announced a dividend on Wednesday, October...